United Rheumatology Newsfeed
Registration now open for “Gaining a Payer Perspective: United Rheumatology, our Members and Payers collaborating to build value-based offerings”
Adults with active ankylosing spondylitis despite treatment with a first TNF-inhibitor, as well as those with stable disease receiving an originator TNF inhibitor, should not be switched to a biosimilar, according to updated … Read moreACR cautions against switching patients with AS, axSpA to biosimilars
A U.S. District Court judge has ruled in favor of Amgen in its lawsuit against Novartis’ Sandoz, which claimed patent infringement on its biologic etanercept by the biosimilar, etanercept-szzs.During litigation, Amgen argued that … Read moreCourt ruling upholds Enbrel patent claim, blocks biosimilar rivals
ORLANDO — The current role of pharmacy benefit managers as “controllers” in the center of the prescription drug market has been detrimental to both patients and physicians, according to Robert. W. Levin, MD, … Read morePBMs blamed for step therapy, nonmedical switching, other restrictions on patients
Patients receiving buprenorphine for treatment of opioid use disorder were more likely to use medications for unrelated, chronic conditions like depression, a study published in Medical Care revealed.“Given the increasing buprenorphine use for … Read moreBuprenorphine for opioid dependence may improve treatment adherence for depression
HILTON HEAD, S.C. — A variant of the apolipoprotein L gene could help explain why patients of African ancestry with lupus typically experience worse disease-related outcomes compared with white patients, according to Ashira … Read moreAPOL1 variant gene may explain lupus outcome disparities between black, white patients
The new JAK inhibitor is approved for adults with moderate to severe RA who can’t tolerate methotrexate or don’t respond sufficiently to it. The post FDA Approves Rinvoq, a New JAK Inhibitor, for … Read moreFDA Approves Rinvoq, a New JAK Inhibitor, for Rheumatoid Arthritis
If you have arthritis, you’ve probably used or contemplated using corticosteroids. Which means you’ve likely also heard some of these common misconceptions. The post 7 Myths About Corticosteroids Rheumatologists Want to Clear Up, … Read more7 Myths About Corticosteroids Rheumatologists Want to Clear Up, Once and for All
Arthritis joint pain plus psoriasis skin plaques: Here’s what increases the risk of developing psoriatic arthritis. The post Psoriatic Arthritis Risk Factors and Causes You Need to Know About appeared first on CreakyJoints.
UPPER NYACK, NY (August 21, 2019) – CreakyJoints®, a Global Healthy Living Foundation digital patient community for people with all forms of arthritis, represents the patient perspective among distinguished health provider professional organizations, … Read moreCreakyJoints Contributes to National Committee for Quality Assurance’s (NCQA) Value-Based Care Model Amplifying Patients’ Voices in Treatment Decisions
Medication changes are common when you’re managing a chronic disease like arthritis. Here’s how to navigate them like a pro. The post 14 Things You Should Do Any Time You Start a New … Read more14 Things You Should Do Any Time You Start a New Medication for Arthritis
California legislation to prevent surprise billing did not result in a reduction of in-network doctors—at least among physicians outside the Kaiser Permanente network, a new study from the top insurer group found.
The health insurance industry has made strides digitizing and automating many of its core processes, yet prior authorization remains a largely manual, cumbersome process.
Veterans Health Administration medical facilities currently have a backlog of nearly 600,000 documents that still need to be digitized as of July 2018, according to the VA OIG. If those paper medical documents were … Read moreVA's paper health records digitization backlog is 5 miles high, VA OIG says
The Department of Health and Human Services is proposing revisions to federal regulations governing the confidentiality of patient records created by federally assisted substance use disorder treatment programs.
The Food and Drug Administration is in discussions with multiple stakeholders to create a universal unique medical device identifier to be stored in electronic health records and linked to patient outcomes to improve … Read moreAbernethy: FDA working with ONC on universal unique device identifier linked to EHR patient data
Rheumatology Advisor Newsfeed
JAMA features a report on the controversy of stem cell treatments for musculoskeletal (MSK) disorders. Stem cell clinics are popular and proliferating as they are largely a cash business and fall outside of … Read moreUnproven But Profitable Stem Cell Clinics
Implementing a treat-to-target approach for the care of rheumatoid arthritis (RA) did not result in an increase in adverse events or resource use, a post-hoc analysis of a randomized trial showed. In an … Read moreTreat-to-Target in RA: No Increase in AEs
In response to the growing opioid crisis, the US Food and Drug Administration has approved the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), designed to reduce the risk of abuse, misuse, … Read moreFDA's Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) Finalized
The Annals of Surgery reports on an anlaysis of FDA-mandated postmarket studies, including nearly 100,000 breast implant pprocedures, that showed silicone implants to be associated with higher rates of Sjögren’s syndrome, scleroderma, rheumatoid … Read moreBreast Implant Study: More Worries or Not?